Looking at Better Ways to Remove Bladder Tumors with Blue Light Treatment
NCT06525571 · RecruitingThis trial looks at two methods for removing bladder tumors in patients with high-risk non-muscle invasive bladder cancer. The goal is to see if using blue light improves how well doctors can remove tumors compared to traditional white light. The study will measure how much cancer remains after surgery and how often it comes back over time. Patients will be randomly assigned to one of the two methods during their treatment.
Locations and contact
This trial is running at 2 locations in the United States. All of them are currently recruiting.
United States2 locations · 2 recruiting
- Johns Hopkins University School of MedicineBaltimore, MarylandRecruiting
- Sibley Memorial HospitalWashington D.C., District of ColumbiaRecruiting
Who can join
This study is for adults aged 18 and older who are having surgery for a bladder tumor. It includes both men and women. Some patients may not be eligible if they have certain types of bladder cancer or a history of pelvic radiation. The trial team will check to see who can take part.
What happens during the trial
Participants will be divided into two groups. One group will have surgery using blue light technology, while the other group will use standard white light. Everyone will receive standard care after surgery, including tests to check for remaining cancer.
The trial team
The trial is sponsored by Johns Hopkins University, with collaboration from Photocure ASA. Dr. Armine Smith from Sibley Memorial Hospital is the principal investigator leading the study.
Important dates
This trial started on December 20, 2024, and is currently recruiting new participants. It is expected to be completed by January 4, 2028.
Additional information
The trial's ID number is NCT06525571. It is a Phase 3 trial, which means it is looking at how well the treatments work and how safe they are. About 200 participants are expected to join this trial. The treatments used in this study are regulated by the FDA.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →